Isidoro Quiroga Moreno - 30 Jul 2021 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Aug 2021, 17:59:04 UTC
Prior SEC filing
03 Aug 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Isidoro Quiroga Moreno

Key filing fact

Isidoro Quiroga Moreno filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 03 Aug 2021.

Key facts

  • This page summarizes Isidoro Quiroga Moreno's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Aug 2021, 17:59.

Change

  • Previous filing in this sequence was filed on 03 Aug 2021.
  • Current net transaction value: +$71,088,067.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RANI transaction

Class A Common Stock

Purchase

Transaction value
$1,788,067
Shares
+158,904
Change %
+3%
Price
$11.25
Shares after
5,431,654
Date
30 Jul 2021
Ownership
Shares indirectly held through Aequanimitas Limited Partnership
Footnotes
F1, F4
RANI transaction

Class A Common Stock

Purchase

Transaction value
$30,000,003
Shares
+2,727,273
Change %
+50%
Price
$11.00
Shares after
8,158,927
Date
03 Aug 2021
Ownership
Shares indirectly held through Aequanimitas Limited Partnership
Footnotes
F2, F4
RANI transaction

Class A Common Stock

Purchase

Transaction value
$39,299,997
Shares
+3,572,727
Change %
+44%
Price
$11.00
Shares after
11,731,654
Date
03 Aug 2021
Ownership
Shares indirectly held through South Lake One LLC
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Aequanimitas Limited Partnership ("Aequanimitas") acquired 158,904 shares of the Issuer's Class A Common Stock in a single transaction in the open market at a price of $11.2525 per share of Class A Common Stock for an aggregate purchase price of $1,788,067.26.

Footnote F2

In connection with the Issuer's initial public offering, Aequanimitas acquired, at a price of $11.00 per share of Class A Common Stock, 2,727,273 shares of the Issuer's Class A Common Stock for an aggregate purchase price of $30,000,003.

Footnote F3

In connection with the Issuer's initial public offering, South Lake One LLC ("South Lake") acquired, at a price of $11.00 per share of Class A Common Stock, 3,572,727 shares of the Issuer's Class A Common Stock for an aggregate purchase price of $39,299,997.

Footnote F4

Isidoro Quiroga Moreno indirectly controls Aequanimitas, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. Aequanimitas is controlled by its general partner, South Lake Three LLC, which is wholly owned by South Cone Investments Limited Partnership ("South Cone"), which is controlled by its general partner Inversiones El Aromo Limitada ("El Aromo"), which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo).

Footnote F5

Isidoro Quiroga Moreno indirectly controls South Lake, which has sole voting power and sole dispositive power with respect to all of the shares of the Issuer's Class A Common Stock held by it. South Lake is wholly owned by South Cone, which is controlled by its general partner El Aromo, which is controlled by Isidoro Quiroga Moreno (who directly owns approximately 71% of the issued and outstanding capital stock of El Aromo).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .